• Mashup Score: 0

    Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the patient population for immunoglobulin A (IgA) nephropathy.

    Tweet Tweets with this article
    • Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the patient population for #ImmunoglobulinA (#IgA) #nephropathy. https://t.co/4idV6CAaEz The IGA Nephropathy Foundation of America @IGANFoundation IGA Nephropathy Foundation

  • Mashup Score: 0

    Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.

    Tweet Tweets with this article
    • Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the current standard of care for #ImmunoglobulinA (#IgA) #nephropathy. Read more: https://t.co/LUlmCk4eSk @IGANFoundation IGA Nephropathy Foundation The IGA Nephropathy Foundation of America

  • Mashup Score: 0
    Captcha - 3 year(s) ago

    checkrare.com is protected by Imunify360 We have noticed an unusual activity from your IP 18.224.110.20 and blocked access to this website. …

    Tweet Tweets with this article
    • Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the patient population for #ImmunoglobulinA (#IgA) #nephropathy. https://t.co/4idV6CAaEz The IGA Nephropathy Foundation of America @IGANFoundation IGA Nephropathy Foundation

  • Mashup Score: 0

    Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.

    Tweet Tweets with this article
    • Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the current standard of care for #ImmunoglobulinA (#IgA) #nephropathy. Read more: https://t.co/LUlmCk4eSk @IGANFoundation IGA Nephropathy Foundation The IGA Nephropathy Foundation of America

  • Mashup Score: 0

    Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.

    Tweet Tweets with this article
    • Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the current standard of care for #ImmunoglobulinA (#IgA) #nephropathy. Read more: https://t.co/LUlmCk4eSk @IGANFoundation IGA Nephropathy Foundation The IGA Nephropathy Foundation of America

  • Mashup Score: 0

    Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the patient population for immunoglobulin A (IgA) nephropathy.

    Tweet Tweets with this article
    • Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the patient population for #ImmunoglobulinA (#IgA) #nephropathy. https://t.co/4idV6CAaEz The IGA Nephropathy Foundation of America @IGANFoundation IGA Nephropathy Foundation

  • Mashup Score: 0

    Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.

    Tweet Tweets with this article
    • Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the current standard of care for #ImmunoglobulinA (#IgA) #nephropathy. Read more: https://t.co/LUlmCklPJS @IGANFoundation IGA Nephropathy Foundation The IGA Nephropathy Foundation of America

  • Mashup Score: 0

    Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the patient population for immunoglobulin A (IgA) nephropathy.

    Tweet Tweets with this article
    • Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the patient population for #ImmunoglobulinA (#IgA) #nephropathy. https://t.co/4idV6CAaEz The IGA Nephropathy Foundation of America @IGANFoundation IGA Nephropathy Foundation

  • Mashup Score: 0

    Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.

    Tweet Tweets with this article
    • Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the current standard of care for #ImmunoglobulinA (#IgA) #nephropathy. Read more: https://t.co/LUlmCk4eSk @IGANFoundation IGA Nephropathy Foundation The IGA Nephropathy Foundation of America